Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1α with membrane ligands of CD4+ CXCR4+ cells

Virology

Volumn 265, Issue 2, 1999, Pages 354-364

  Mbemba, Elisabeth ^a   Benjouad, A ^b,c   Saffar, L ^a   Gattegno, L ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b FACULTÉ DES SCIENCES   (Morocco)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE; GLYCOPROTEIN GP 120; LIGAND; PROTEOGLYCAN; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STROMA CELL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033590169     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0033     Document Type: Article

References (39)

1. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR-5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
2. Amara A., Le Gall S., Schwartz O., Salamero J., Montes M., Loetscher P., Baggiolini M., Virelizier J. L., Arenzada-Seisdedos F. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:1997;139-146.
3. Amzazi S., Ylisastigui L., Bakri Y., Rabehi L., Gattegno L., Parmentier M., Gluckman J. C., Benjouad A. The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state. Virology. 252:1998;96-105.
4. Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E. Mechanism of inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA. 9:1988;335-343.
5. Batinic D., Robey F. A. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267:1992;6664-6671.
6. Bleul C. C., Farzan M., Chloe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A. The lymphocyte chemoattractant SDF-1 is a ligand for CXCR4/fusion and blocks HIV entry. Nature. 282:1996;829-833.
7. Berger E. A., Doms R. W., Fenyö E. M., Korber B. T. M., Littman D. R., Moore J. P., Sattentau Q. J., Schuitemaker H., Sodroski J., Weiss R. A. A new classification for HIV-1. Nature. 391:1998;240.
8. Brelot A., Heveker N., Pleskoff O., Sol N., Alizon M. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J. Virol. 71:1997;4744-4751.
9. + T cells. Science. 270:1995;1811-1815.
10. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major coreceptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
11. D'Souza M. P., Harden V. A. Chemokines and HIV-1 second receptors. Nat. Med. 2:1996;1293-1300.
12. Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the β chemokine receptors CKR-5, CKR-3, CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
13. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
14. Endres M. J., Clapham P. R., Marsh M., Ahuja M., Davis Turner J., McKnight A., Thomas J. F., Stoebenau-Haggartty S., Choe P. J., Vance T. N. C., Wells C. A., Power S. S., Sutterwals R. W., Landau N. R., Hoxie J. A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell. 87:1996;872-877.
15. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV entry cofactor, functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-876.
16. Feito M. J., Bragardo M., Buofiglio D., Bonissoni S., Bottarel F., Malavasi F., Dianzani U. Gp120s derived from four syncytium-inducing HIV-1 strains induce different patterns of CD4 association with lymphocyte surface molecules. Int. Immunol. 9:1996;1141-1147.
17. Hesselgesser J., Liang M., Hoxie J., Greenberg M., Bras L. F., Orsini M., Taub D., Horuck R. Identification of the CXCR4 chemokine receptor in human T cell line: Ligand binding, biological activity, and HIV-1 infectivity. J. Immunol. 160:1998;877-883.
18. Haidar M., Seddiki N., Gluckman J. C., Gattegno L. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus 1. Glycoconj. J. 9:1992;315-323.
19. Haidar M., Gluckman J. C., Gattegno L. Mannosy/N-acetyl-β-D-glucosaminyl binding properties of the envelope glycoproteins of human immunodeficiency virus type 2. Glycobiology. 2:1992;429-435.
20. Hilary A. H., Rider C. C. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4. Glycobiology. 8:1998;131-137.
21. Javaherian K., Khiroya R., Quinlan C., Boyd G. B., Hantham K. A. V3-mediated heparin neutralization of HIV type 1. AIDS. Res. Hum. Retroviruses. 10:1994;1421-1423.
22. Kage A., Shoolian E., Rokos K., Özel M., Nuck R., Reutter W., Köttgen E., Pauli G. Epithelial uptake and transport of cell-free human immunodeficiency virus type-1 and gp120-coated microparticles. J. Virol. 72:1998;4231-4236.
23. Klatzmann D. R., McDougal J. S., Maddon P. J. The CD4 molecule and HIV infection. Immunodefic. Rev. 2:1990;43-66.
24. Lapham C. K., Ouyang J., Chandrasekhar B., Nguyen N. G., Dimitrov D. S., Golding H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science. 274:1996;602-605.
25. + cells by CD4-free glycopeptides from monocytic U937 cells. AIDS. Res. Hum. Retroviruses. 12:1996;47-53.
26. Mbemba E., Czersky J., Gattegno L. Molecular interactions between the HIV-1 major envelope glycoprotein and heparin. Biochim. Biophys. Acta. 1180:1992;123-129.
27. Mbemba E., Gluckman J. C., Gattegno L. Interactions of HIV-1 and HIV-1 envelope glycoproteins with sulfated polysaccharides and mannose-6-phosphate. Glycobiology. 4:1994;13-21.
28. Oberlin E., Amara A., Bachelirie F., Bessia C., Virelizier J. L., Arenzana-Seisdedos F., Schwartz O., Heard J. M., Clark-Lewis I., Legler D. F., Loetscher M., Baggiolini M., Moser B. T CXC chemokine SDF-1 is the ligand for LESTR: fusin and prevents infection by T-cell line-adapted HIV-1. Nature. 382:1996;833-837.
29. Oravecz T., Pall M., Norcross M. A. Beta-chemokine inhibition of monocytotropic HIV-1 infection: Interference with a post-binding fusion step. J. Immunol. 157:1996;1329-1332.
30. Premack B. A., Schall T. Chemokine receptors: gateways to inflammation and infection. Nat. Med. 2:1996;1174-1178.
31. Rabehi L., Seddiki N., Benjouad A., Gluckman J. C., Gattegno L. Interactions of human immunodeficiency virus type 1(HIV-1) envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages. AIDS. Res. Hum. Retroviruses. 18:1998;1605-1615.
32. Sakaika H., Hori T., Yonezawa A., Sato A., Isaka Y., Yoshie O., Hattori T., Uchimaya T. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR4 and inhibit T-tropic HIV-1 infection. J. Virol. 12:1998;9763-9770.
33. Seddiki N., Rabehi L., Benjouad A., Saffar L., Ferriere F., Gluckman J. C., Gattegno L. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes. Glycobiology. 7:1997;1229-1236.
34. Scarlatti G., Tresoldi E., Björnald A., Fredrikson R., Colognesi C., Deng H. K., Malnati M. S., Plebani A., Siccardi A. G., Littman D. R., Fenyö E. M., Lusso P. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 11:1997;1259-1265.
35. Simmons G., Clapham P. R., Picard L., Offord R. E., Rosenkilde M. M., Schwartz T. W., Buser R., Wells T. N. C., Proodfoot A. E. I. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 276:1997;276-279.
36. Simmons G., Reeves J. D., McKnight A., Dejucq N., Hibbitts S., Power C. A., Aarons E., Schols D., De Clercq E., Amanda E., Proudfoot I., Clapham P. R. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J. Virol. 72:1998;8453-8457.
37. Szmelcman S., Clément J. M., Jehanno M., Scwartz O., Montagner L., Hofnung M. Export and one-step purification from Escherichia coli of a MalE-CD4 hybrid protein that neutralizes HIV In vitro. J. Acquir. Immune Defic. Syndr. 3:1990;859-872.
38. Ugolini S., Moulard M., Mondor I., Barois N., Demandolx D., Hoxie J., Brelot A., Alizon M., Davoust J., Sattentau Q. J. HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4. J. Immunol. 159:1997;3000-3008.
39. Ylisatigui L., Vizzavona J., Drakopoulo E., Paindavoine P., Calvo C. F., Parmentier M., Gluckman J. C., Vita C., Benjouad A. Synthetic full-length and truncated RANTES inhibit human immunodeficiency virus type 1 infection of primary macrophages. AIDS. 12:1998;977-984.